Revivo Therapeutics
Durham, United States (US) · Health and Medical
We built this page from public sources.
Do you work at Revivo Therapeutics?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
#cognitive decline
#alzheimer's disease
#traumatic brain injury
#mild cognitive impairment
Revivo Therapeutics is a Durham, North Carolina-based clinical stage biotechnology company focused on developing innovative small molecule therapies to combat cognitive decline.We are dedicated to addressing the growing global challenge of conditions like Alzheimer’s Disease and Mild Cognitive Impairment (MCI).
Overview
We are dedicated to addressing the growing global challenge of conditions like Alzheimer’s Disease and Mild Cognitive Impairment (MCI). Our core research and development efforts center around RIV-5061, a novel drug candidate designed to target the underlying mechanisms of cognitive impairment.
Revivo Therapeutics leverages a proprietary platform to identify and develop targeted therapies, offering a potential new approach to treating debilitating neurological conditions. We are currently seeking funding to support Phase 1/1b clinical trials, bringing our promising drug candidate closer to patients.
Founded in 2016, Revivo Therapeutics is comprised of a dedicated team of scientists and experts committed to transforming the landscape of cognitive health.
Contact Details
Durham, United States (US), 2530 Meridian Pkwy
Founded
2016
Company Type
Private Limited Company
Employees
2-10
Categories
Keywords
#cognitive decline
#alzheimer's disease
#traumatic brain injury
#mild cognitive impairment
Companies teams usually look at after Revivo Therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.